Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
467671000001114 | Rimegepant 75mg oral lyophilisates sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
467681000001111 | Rimegepant 75mg oral lyophilisates sugar free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Vydura 75mg oral lyophilisates (Pfizer Ltd) | Is a | True | Rimegepant 75mg oral lyophilisates sugar free | Inferred relationship | Existential restriction modifier | |
Rimegepant 75mg oral lyophilisates sugar free 2 tablet | Has VMP | True | Rimegepant 75mg oral lyophilisates sugar free | Inferred relationship | Existential restriction modifier | |
Rimegepant 75mg oral lyophilisates sugar free 8 tablet | Has VMP | True | Rimegepant 75mg oral lyophilisates sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets